{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:42:59Z","timestamp":1791726179836,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Societe fran\u00e7aise d'Endocrinologie"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02930-2","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:15:41Z","timestamp":1759313741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Testosterone therapy is associated with reduced risk of acute kidney injury, kidney failure with renal replacement therapy, and cardiovascular events in men with diabetes and hypogonadism"],"prefix":"10.1186","volume":"24","author":[{"given":"Fabrice","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Vaduva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Dosda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Henri","family":"Ducluzeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Koppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"10225","key":"2930_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBDCKD Collaboration","year":"2020","unstructured":"Collaboration GBDCKD. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"9","key":"2930_CR2","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1210\/jc.2010-2724","volume":"96","author":"P Dandona","year":"2011","unstructured":"Dandona P, Dhindsa S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab. 2011;96(9):2643\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2930_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s40618-016-0480-2","volume":"39","author":"G Corona","year":"2016","unstructured":"Corona G, Giagulli VA, Maseroli E, Vignozzi L, Aversa A, Zitzmann M, Saad F, Mannucci E, Maggi M. Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest. 2016;39(9):967\u201381.","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2930_CR4","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/dom.12701","volume":"18","author":"LV Magnussen","year":"2016","unstructured":"Magnussen LV, Glintborg D, Hermann P, Hougaard DM, Hojlund K, Andersen M. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on Metformin monotherapy. Diabetes Obes Metab. 2016;18(10):980\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"2930_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/bju.14536","volume":"123","author":"G Hackett","year":"2019","unstructured":"Hackett G, Cole N, Mulay A, Strange RC, Ramachandran S. Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors. BJU Int. 2019;123(3):519\u201329.","journal-title":"BJU Int"},{"key":"2930_CR6","first-page":"100365","volume":"37","author":"M Zitzmann","year":"2024","unstructured":"Zitzmann M. Testosterone deficiency and chronic kidney disease. J Clin Transl Endocrinol. 2024;37:100365.","journal-title":"J Clin Transl Endocrinol"},{"issue":"1","key":"2930_CR7","doi-asserted-by":"publisher","first-page":"10726","DOI":"10.1038\/s41598-018-29023-3","volume":"8","author":"G Zhang","year":"2018","unstructured":"Zhang G, Kang Y, Zhou C, Cui R, Jia M, Hu S, Ji X, Yuan J, Cui H, Shi G. Amelioratory effects of testosterone propionate on age-related renal fibrosis via suppression of TGF-beta1\/Smad signaling and activation of Nrf2-ARE signaling. Sci Rep. 2018;8(1):10726.","journal-title":"Sci Rep"},{"issue":"9","key":"2930_CR8","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S0026-0495(99)90123-3","volume":"48","author":"MM Kau","year":"1999","unstructured":"Kau MM, Lo MJ, Wang SW, Tsai SC, Chen JJ, Chiao YC, Yeh JY, Lin H, Shum AY, Fang VS, et al. Inhibition of aldosterone production by testosterone in male rats. Metabolism. 1999;48(9):1108\u201314.","journal-title":"Metabolism"},{"issue":"11","key":"2930_CR9","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1111\/dom.14122","volume":"22","author":"KS Haider","year":"2020","unstructured":"Haider KS, Haider A, Saad F, Doros G, Hanefeld M, Dhindsa S, Dandona P, Traish A. Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study. Diabetes Obes Metab. 2020;22(11):2055\u201368.","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"2930_CR10","first-page":"2670","volume":"85","author":"PJ Snyder","year":"2000","unstructured":"Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab. 2000;85(8):2670\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2930_CR11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1161\/CIRCULATIONAHA.119.044235","volume":"141","author":"CD Mazer","year":"2020","unstructured":"Mazer CD, Hare GMT, Connelly PW, Gilbert RE, Shehata N, Quan A, Teoh H, Leiter LA, Zinman B, Juni P, et al. Effect of empagliflozin on erythropoietin levels, iron stores, and red blood cell morphology in patients with type 2 diabetes mellitus and coronary artery disease. Circulation. 2020;141(8):704\u20137.","journal-title":"Circulation"},{"issue":"9","key":"2930_CR12","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/ndt\/gfae032","volume":"39","author":"C Wanner","year":"2024","unstructured":"Wanner C, Nangaku M, Kraus BJ, Zinman B, Mattheus M, Hantel S, Schumacher M, Ohneberg K, Schmoor C, Inzucchi SE. How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial. Nephrol Dial Transpl. 2024;39(9):1504\u201313.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"2930_CR13","doi-asserted-by":"publisher","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, Esposito J, Claerhout B. A global federated real-world data and analytics platform for research. JAMIA Open. 2023;6(2):ooad035.","journal-title":"JAMIA Open"},{"issue":"10","key":"2930_CR14","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1111\/dom.15185","volume":"25","author":"DR Riley","year":"2023","unstructured":"Riley DR, Essa H, Austin P, Preston F, Kargbo I, Ibarburu GH, Ghuman R, Cuthbertson DJ, Lip GYH, Alam U. All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes. Diabetes Obes Metab. 2023;25(10):2897\u2013909.","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"2930_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jamaneurol.2024.2057","volume":"81","author":"EK Acton","year":"2024","unstructured":"Acton EK, Hennessy S, Gelfand MA, Leonard CE, Bilker WB, Shu D, Willis AW, Kasner SE. Direct-Acting oral anticoagulants and Antiseizure medications for atrial fibrillation and epilepsy and risk of thromboembolic events. JAMA Neurol. 2024;81(8):835\u201344.","journal-title":"JAMA Neurol"},{"key":"2930_CR16","doi-asserted-by":"crossref","unstructured":"Bucci T, Nabrdalik K, Baratta F, Pastori D, Pignatelli P, Hydes T, Alam U, Violi F, Lip GYH. Risk of adverse events in anticoagulated patients with atrial fibrillation and non-alcoholic fatty liver disease. J Clin Endocrinol Metab 2024.","DOI":"10.1210\/clinem\/dgae394"},{"issue":"3","key":"2930_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/jama.2013.8638","volume":"310","author":"F Lapi","year":"2013","unstructured":"Lapi F, Azoulay L, Niazi MT, Yin H, Benayoun S, Suissa S. Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA. 2013;310(3):289\u201396.","journal-title":"JAMA"},{"issue":"4","key":"2930_CR18","doi-asserted-by":"publisher","first-page":"e371371","DOI":"10.1016\/j.jamda.2016.01.011","volume":"17","author":"N Kurita","year":"2016","unstructured":"Kurita N, Horie S, Yamazaki S, Otani K, Sekiguchi M, Onishi Y, Takegami M, Ono R, Konno S, Kikuchi S, et al. Low testosterone levels and reduced kidney function in Japanese adult men: the locomotive syndrome and health outcome in Aizu cohort study. J Am Med Dir Assoc. 2016;17(4):e371371\u2013376.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"2930_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2215025","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM Jr, et al. Cardiovascular safety of Testosterone-Replacement therapy. N Engl J Med. 2023;389(2):107\u201317.","journal-title":"N Engl J Med"},{"issue":"1","key":"2930_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12933-019-0901-6","volume":"18","author":"C Wang","year":"2019","unstructured":"Wang C, Zhang W, Wang Y, Wan H, Chen Y, Xia F, Zhang K, Wang N, Lu Y. Novel associations between sex hormones and diabetic vascular complications in men and postmenopausal women: a cross-sectional study. Cardiovasc Diabetol. 2019;18(1):97.","journal-title":"Cardiovasc Diabetol"},{"issue":"Pt 1","key":"2930_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1113\/jphysiol.2002.022756","volume":"543","author":"C Molinari","year":"2002","unstructured":"Molinari C, Battaglia A, Grossini E, Mary DA, Vassanelli C, Vacca G. The effect of testosterone on regional blood flow in prepubertal anaesthetized pigs. J Physiol. 2002;543(Pt 1):365\u201372.","journal-title":"J Physiol"},{"issue":"4","key":"2930_CR22","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1161\/HYPERTENSIONAHA.107.100594","volume":"51","author":"Q Xu","year":"2008","unstructured":"Xu Q, Wells CC, Garman JH, Asico L, Escano CS, Maric C. Imbalance in sex hormone levels exacerbates diabetic renal disease. Hypertension. 2008;51(4):1218\u201324.","journal-title":"Hypertension"},{"key":"2930_CR23","doi-asserted-by":"publisher","first-page":"118138","DOI":"10.1016\/j.lfs.2020.118138","volume":"257","author":"AF Melo Junior","year":"2020","unstructured":"Melo Junior AF, Dalpiaz PLM, Escouto LDS, Sousa GJ, Aires R, Oliveira ND, Carmona AK, Gava AL, Bissoli NS. Involvement of sex hormones, oxidative stress, ACE and ACE2 activity in the impairment of renal function and remodelling in SHR. Life Sci. 2020;257:118138.","journal-title":"Life Sci"},{"issue":"11","key":"2930_CR24","doi-asserted-by":"publisher","first-page":"R951","DOI":"10.1152\/ajpregu.00360.2012","volume":"304","author":"A Soljancic","year":"2013","unstructured":"Soljancic A, Ruiz AL, Chandrashekar K, Maranon R, Liu R, Reckelhoff JF, Juncos LA. Protective role of testosterone in ischemia-reperfusion-induced acute kidney injury. Am J Physiol Regul Integr Comp Physiol. 2013;304(11):R951\u2013958.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"2930_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.genm.2012.02.003","volume":"9","author":"Y Lu","year":"2012","unstructured":"Lu Y, Fu Y, Ge Y, Juncos LA, Reckelhoff JF, Liu R. The vasodilatory effect of testosterone on renal afferent arterioles. Gend Med. 2012;9(2):103\u201311.","journal-title":"Gend Med"},{"issue":"2","key":"2930_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1212\/01.WNL.0000149639.25136.CA","volume":"64","author":"MM Cherrier","year":"2005","unstructured":"Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, Raskind MA, Johnson M, Craft S. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005;64(2):290\u20136.","journal-title":"Neurology"},{"issue":"5","key":"2930_CR27","doi-asserted-by":"publisher","first-page":"F1678","DOI":"10.1152\/ajprenal.00079.2007","volume":"293","author":"A Dixon","year":"2007","unstructured":"Dixon A, Maric C. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am J Physiol Ren Physiol. 2007;293(5):F1678\u20131690.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"11","key":"2930_CR28","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ki.2009.69","volume":"75","author":"P Catanuto","year":"2009","unstructured":"Catanuto P, Doublier S, Lupia E, Fornoni A, Berho M, Karl M, Striker GE, Xia X, Elliot S. 17 beta-estradiol and Tamoxifen upregulate Estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int. 2009;75(11):1194\u2013201.","journal-title":"Kidney Int"},{"issue":"3","key":"2930_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/sj.ki.5002690","volume":"73","author":"A Satake","year":"2008","unstructured":"Satake A, Takaoka M, Nishikawa M, Yuba M, Shibata Y, Okumura K, Kitano K, Tsutsui H, Fujii K, Kobuchi S, et al. Protective effect of 17beta-estradiol on ischemic acute renal failure through the PI3K\/Akt\/eNOS pathway. Kidney Int. 2008;73(3):308\u201317.","journal-title":"Kidney Int"},{"issue":"6","key":"2930_CR30","doi-asserted-by":"publisher","first-page":"768","DOI":"10.7326\/M23-2781","volume":"177","author":"BB Yeap","year":"2024","unstructured":"Yeap BB, Marriott RJ, Dwivedi G, Adams RJ, Antonio L, Ballantyne CM, Bauer DC, Bhasin S, Biggs ML, Cawthon PM, et al. Associations of testosterone and related hormones with All-Cause and cardiovascular mortality and incident cardiovascular disease in men: individual participant data Meta-analyses. Ann Intern Med. 2024;177(6):768\u201381.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2930_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.ajkd.2014.03.010","volume":"64","author":"KK Khurana","year":"2014","unstructured":"Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV Jr., Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3\u20134. Am J Kidney Dis. 2014;64(3):367\u201374.","journal-title":"Am J Kidney Dis"},{"issue":"16","key":"2930_CR32","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jacc.2011.07.019","volume":"58","author":"C Ohlsson","year":"2011","unstructured":"Ohlsson C, Barrett-Connor E, Bhasin S, Orwoll E, Labrie F, Karlsson MK, Ljunggren O, Vandenput L, Mellstrom D, Tivesten A. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic fractures in Men) study in Sweden. J Am Coll Cardiol. 2011;58(16):1674\u201381.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2930_CR33","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.2337\/dc09-1649","volume":"33","author":"S Dhindsa","year":"2010","unstructured":"Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A, Dandona P. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33(6):1186\u201392.","journal-title":"Diabetes Care"},{"issue":"4","key":"2930_CR34","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.kint.2017.10.020","volume":"93","author":"M Pruijm","year":"2018","unstructured":"Pruijm M, Milani B, Pivin E, Podhajska A, Vogt B, Stuber M, Burnier M. Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease. Kidney Int. 2018;93(4):932\u201340.","journal-title":"Kidney Int"},{"issue":"4","key":"2930_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ncpneph0757","volume":"4","author":"DK Singh","year":"2008","unstructured":"Singh DK, Winocour P, Farrington K. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol. 2008;4(4):216\u201326.","journal-title":"Nat Clin Pract Nephrol"},{"issue":"3","key":"2930_CR36","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.kint.2020.04.051","volume":"98","author":"J Li","year":"2020","unstructured":"Li J, Neal B, Perkovic V, de Zeeuw D, Neuen BL, Arnott C, Simpson R, Oh R, Mahaffey KW, Heerspink HJL. Mediators of the effects of Canagliflozin on kidney protection in patients with type 2 diabetes. Kidney Int. 2020;98(3):769\u201377.","journal-title":"Kidney Int"},{"issue":"2","key":"2930_CR37","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2337\/dc17-1096","volume":"41","author":"SE Inzucchi","year":"2018","unstructured":"Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, Schmoor C, Ohneberg K, Johansen OE, George JT, et al. How does empagliflozin reduce cardiovascular mortality?? Insights from a mediation analysis of the EMPA-REG OUTCOME trial. Diabetes Care. 2018;41(2):356\u201363.","journal-title":"Diabetes Care"},{"issue":"6","key":"2930_CR38","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1002\/ehf2.13615","volume":"8","author":"D Fitchett","year":"2021","unstructured":"Fitchett D, Inzucchi SE, Zinman B, Wanner C, Schumacher M, Schmoor C, Ohneberg K, Ofstad AP, Salsali A, George JT, et al. Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial. ESC Heart Fail. 2021;8(6):4517\u201327.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"2930_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/dc15-1518","volume":"39","author":"S Dhindsa","year":"2016","unstructured":"Dhindsa S, Ghanim H, Batra M, Kuhadiya ND, Abuaysheh S, Sandhu S, Green K, Makdissi A, Hejna J, Chaudhuri A, et al. Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes. Diabetes Care. 2016;39(1):82\u201391.","journal-title":"Diabetes Care"},{"key":"2930_CR40","doi-asserted-by":"crossref","unstructured":"Crafa A, Condorelli RA, Mongioi LM, Cannarella R, Barbagallo F, Aversa A, Izzo G, Perri A, Calogero AE, La Vignera S. Mean platelet volume as a marker of vasculogenic erectile dysfunction and future cardiovascular risk. J Clin Med 2020, 9(8).","DOI":"10.3390\/jcm9082513"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02930-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:15:43Z","timestamp":1759313743000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02930-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2930"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02930-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}